Not Rated
|
Fund Size
(0.02% of Investment in Category)
|
Expense Ratio
(0.89% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Rank within Category | |
|---|---|---|---|---|---|---|
| No Data Found | ||||||
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| No Data Found | |||||
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 128.5 | 12.26% | -0.02% | 13.47% (Dec 2024) | 0% (Oct 2024) | 80.57 k | -2.14 k |
| Divis Laboratories Ltd. | Pharmaceuticals | 88.1 | 8.40% | -0.44% | 8.84% (Aug 2025) | 0% (Oct 2024) | 15.48 k | 0.00 |
| Max Healthcare Institute Ltd. | Hospital | 77.6 | 7.40% | -0.08% | 7.94% (Jun 2025) | 0% (Oct 2024) | 69.59 k | 0.00 |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 67.2 | 6.41% | -0.03% | 6.52% (Dec 2024) | 0% (Oct 2024) | 54.89 k | 0.00 |
| Aster DM Healthcare Ltd. | Hospital | 63.9 | 6.09% | 0.39% | 6.09% (Sep 2025) | 0% (Oct 2024) | 1.02 L | 0.00 |
| Mankind Pharma Ltd. | Pharmaceuticals | 54.7 | 5.22% | 0.05% | 5.22% (Sep 2025) | 0% (Oct 2024) | 22.45 k | 0.00 |
| J.b. Chemicals & Pharmaceuticals Ltd. | Pharmaceuticals | 49.2 | 4.70% | 2.53% | 4.7% (Sep 2025) | 0% (Oct 2024) | 28.79 k | 15.27 k |
| Krishna Institute of Medical Sciences Ltd. | Hospital | 41 | 3.91% | -0.04% | 3.95% (Aug 2025) | 0% (Oct 2024) | 58.58 k | 0.00 |
| Abbott India Ltd. | Pharmaceuticals | 34.8 | 3.32% | -0.16% | 3.79% (Jun 2025) | 0% (Oct 2024) | 1.19 k | 0.00 |
| Global Health Ltd. | Hospital | 34.8 | 3.32% | -0.07% | 3.39% (Aug 2025) | 0% (Oct 2024) | 26.47 k | 0.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 1.62% |
| Net Receivables | Net Receivables | 0.08% |
Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)
No data available. Ratios are only available for the funds which are 3 years old.
Out of 24 mutual fund schemes offered by this AMC, 1 is/are ranked 5 * , 3 is/are ranked 4 * , 3 is/are ranked 3 * , 4 is/are ranked 2 * , 2 is/are ranked 1 * , and 11 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| PGIM India Midcap Fund - Direct Plan - Growth | 2 | 11326.40 | -1.42 | 0.07 | 7.95 | 4.02 | 14.15 |
| PGIM India Flexi Cap Fund - Direct Plan - Growth | 2 | 6193.15 | 0.28 | 2.45 | 7.18 | 6.10 | 14.22 |
| PGIM India Global Equity Opportunities Fund of Fund - Direct Plan - Growth | NA | 1614.87 | -2.18 | 5.00 | 18.32 | 8.37 | 25.28 |
| PGIM India Small Cap Fund - Direct Plan - Growth | 3 | 1567.96 | 0.51 | 2.55 | 14.88 | 1.78 | 15.50 |
| PGIM India Balanced Advantage Fund - Direct Plan - Growth | NA | 938.46 | 0.72 | 2.12 | 4.79 | 6.45 | 11.65 |
| PGIM India Large and Midcap Fund - Direct Plan - Growth | NA | 763.24 | -0.85 | 1.18 | 6.45 | 7.33 | 0.00 |
| PGIM India ELSS Tax Saver Fund - Direct Plan - Growth | 2 | 757.48 | 0.70 | 1.84 | 4.62 | 5.08 | 13.83 |
| PGIM India Emerging Markets Equity Fund of Fund - Direct Plan - Growth | NA | 675.50 | -1.71 | 6.93 | 20.60 | 13.61 | 17.81 |
| PGIM India Large Cap Fund - Direct Plan - Growth | 3 | 592.77 | 0.78 | 3.06 | 4.97 | 7.36 | 13.13 |
| PGIM India Liquid Fund - Direct Plan - Growth | 1 | 475.45 | 0.48 | 1.46 | 3.04 | 6.80 | 7.11 |